Table 1.
Unresectable patients (n = 15) | Resectable patients (n = 18) | |
---|---|---|
Age | 60 (41–68) | 61 (33–71) |
Female | 3 | 4 |
Male | 12 | 14 |
Initial operation | ||
Explorative laparotomy | 4 | 8 |
Gastroenterostomy | 5 | 0 |
Double bypass | 3 | 5 |
Lymph node biopsy | 1 | 0 |
Resection of abdominal wall tumor | 1 | 0 |
Laparoscopy | 0 | 2 |
Hepaticojejunostomy | 1 | 3 |
Interval between surgeries (median) | 88 days | 101 days |
Preoperative tumor markers | ||
CA19-9 (median) | 608 U/l | 117 U/l |
CEA (median) | 39143 U/l | 136 U/l |
Diabetes mellitus | 3 | 6 |
Neoadjuvant therapy | 12 | 13 |